Hoxa9 regulates Flt3 in lymphohematopoietic progenitors

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6572-6583

  Gwin, Kimberly ^a   Frank, Elena ^a   Bossou, Ayoko ^a   Medina, Kay L ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY B CELL FACTOR; FLT3 LIGAND; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL FATE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; LYMPHOID PROGENITOR CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; RNA PURIFICATION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; FMS-LIKE TYROSINE KINASE 3; GENE SILENCING; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; LYMPHOPOIESIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANS-ACTIVATORS;

EID: 78650671103     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904203     Document Type: Article

References (58)

1. Medina, K. L., and H. Singh. 2005. Genetic networks that regulate B lymphopoiesis. Curr. Opin. Hematol. 12:203-209.
2. Ramírez, J., K. Lukin, and J. Hagman. 2010. From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment. Curr. Opin. Immunol. 22:177-184.
3. Lai, A. Y., S. M. Lin, and M. Kondo. 2005. Heterogeneity of Flt3-expressing multipotent progenitors in mouse bone marrow. J. Immunol. 175:5016-5023.
4. Sitnicka, E., N. Buza-Vidas, H. Ahlenius, C. M. Cilio, C. Gekas, J. M. Nygren, R. Månsson, M. Cheng, C. T. Jensen, M. Svensson, et al. 2007. Critical role of FLT3 ligand in IL-7 receptor independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors. Blood 110:2955-2964.
5. Dias, S., H. Silva, Jr., A. Cumano, and P. Vieira. 2005. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J. Exp. Med. 201:971-979.
6. Kikuchi, K., A. Y. Lai, C. L. Hsu, and M. Kondo. 2005. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J. Exp. Med. 201:1197-1203.
7. Dias, S., R. Månsson, S. Gurbuxani, M. Sigvardsson, and B. L. Kee. 2008. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity 29:217-227.
8. Romanow, W. J., A. W. Langerak, P. Goebel, I. L. Wolvers-Tettero, J. J. van Dongen, A. J. Feeney, and C. Murre. 2000. E2A and EBF act in synergy with the V (D) J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5:343-353.
9. Yang, Q., L. Kardava, A. St Leger, K. Martincic, B. Varnum-Finney, I. D. Bernstein, C. Milcarek, and L. Borghesi. 2008. E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors. J. Immunol. 181:5885-5894.
10. O'Riordan, M., and R. Grosschedl. 1999. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11:21-31.
11. Ikawa, T., H. Kawamoto, L. Y. Wright, and C. Murre. 2004. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20:349-360.
12. Nutt, S. L., P. Urbánek, A. Rolink, and M. Busslinger. 1997. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11:476-491.
13. Pongubala, J. M., D. L. Northrup, D. W. Lancki, K. L. Medina, T. Treiber, E. Bertolino, M. Thomas, R. Grosschedl, D. Allman, and H. Singh. 2008. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat. Immunol. 9:203-215.
14. Bertolino, E., K. Reddy, K. L. Medina, E. Parganas, J. Ihle, and H. Singh. 2005. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat. Immunol. 6:836-843.
15. Lawrence, H. J., C. D. Helgason, G. Sauvageau, S. Fong, D. J. Izon, R. K. Humphries, and C. Largman. 1997. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:1922-1930.
16. So, C. W., H. Karsunky, P. Wong, I. L. Weissman, and M. L. Cleary. 2004. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood 103:3192-3199.
17. Nutt, S. L., A. M. Morrison, P. Dörfler, A. Rolink, and M. Busslinger. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by lossand gain-of-function experiments. EMBO J. 17:2319-2333.
18. Ceredig, R., J. Andersson, F. Melchers, and A. Rolink. 1999. Effect of deregulated IL-7 transgene expression on B lymphocyte development in mice expressing mutated pre-B cell receptors. Eur. J. Immunol. 29:2797-2807.
19. Medina, K. L., K. P. Garrett, L. F. Thompson, M. I. Rossi, K. J. Payne, and P. W. Kincade. 2001. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat. Immunol. 2:718-724.
20. Medina, K. L., J. M. Pongubala, K. L. Reddy, D. W. Lancki, R. Dekoter, M. Kieslinger, R. Grosschedl, and H. Singh. 2004. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7:607-617.
21. Wilson, A., E. Laurenti, G. Oser, R. C. van der Wath, W. Blanco-Bose, M. Jaworski, S. Offner, C. F. Dunant, L. Eshkind, E. Bockamp, et al. 2008. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135:1118-1129.
22. Lai, A. Y., and M. Kondo. 2006. Asymmetrical lymphoid and myeloid lineage commitmentinmultipotent hematopoietic progenitors. J. Exp. Med. 203:1867-1873.
23. Mizusawa, N., T. Hasegawa, I. Ohigashi, C. Tanaka-Kosugi, N. Harada, M. Itakura, and K. Yoshimoto. 2004. Differentiation phenotypes of pancreatic islet beta-and alpha-cells are closely related with homeotic genes and a group of differentially expressed genes. Gene 331:53-63.
24. Sanyal, M., J. W. Tung, H. Karsunky, H. Zeng, L. Selleri, I. L. Weissman, L. A. Herzenberg, and M. L. Cleary. 2007. B-cell development fails in the absence of the Pbx1 proto-oncogene. Blood 109:4191-4199.
25. Zeisig, B. B., T. Milne, M. P. García-Cuéllar, S. Schreiner, M. E. Martin, U. Fuchs, A. Borkhardt, S. K. Chanda, J. Walker, R. Soden, et al. 2004. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol. Cell. Biol. 24:617-628.
26. Wang, G. G., M. P. Pasillas, and M. P. Kamps. 2006. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemiaassociated genes. Mol. Cell. Biol. 26:3902-3916.
27. DeKoter, R. P., H. J. Lee, and H. Singh. 2002. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16:297-309.
28. Kikuchi, K., H. Kasai, A. Watanabe, A. Y. Lai, and M. Kondo. 2008. IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression. J. Immunol. 181:383-392.
29. Igarashi, H., S. C. Gregory, T. Yokota, N. Sakaguchi, and P. W. Kincade. 2002. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17:117-130.
30. Holmes, M. L., S. Carotta, L. M. Corcoran, and S. L. Nutt. 2006. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev. 20:933-938.
31. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-672.
32. Harman, B. C., D. L. Northrup, and D. Allman. 2008. Resolution of unique Sca-1highc-Kit-lymphoid-biased progenitors in adult bone marrow. J. Immunol. 181:7514-7524.
33. Lee, G., K. Medina, and P. W. Kincade. 1989. Growth requirements of B lineage lymphocytes from scid and normal mice. Curr. Top. Microbiol. Immunol. 152:33-37.
34. Akerblad, P., M. Rosberg, T. Leanderson, and M. Sigvardsson. 1999. The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor. Mol. Cell. Biol. 19:392-401.
35. Sigvardsson, M., M. O'Riordan, and R. Grosschedl. 1997. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7:25-36.
36. Pineault, N., C. D. Helgason, H. J. Lawrence, and R. K. Humphries. 2002. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp. Hematol. 30:49-57.
37. Sauvageau, G., P. M. Lansdorp, C. J. Eaves, D. E. Hogge, W. H. Dragowska, D. S. Reid, C. Largman, H. J. Lawrence, and R. K. Humphries. 1994. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA 91:12223-12227.
38. Sitnicka, E., D. Bryder, K. Theilgaard-Mönch, N. Buza-Vidas, J. Adolfsson, and S. E. Jacobsen. 2002. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17:463-472.
39. Matthews, W., C. T. Jordan, G. W. Wiegand, D. Pardoll, and I. R. Lemischka. 1991. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143-1152.
40. Lawrence, H. J., J. Christensen, S. Fong, Y. L. Hu, I. Weissman, G. Sauvageau, R. K. Humphries, and C. Largman. 2005. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 106:3988-3994.
41. Adolfsson, J., O. J. Borge, D. Bryder, K. Theilgaard-Mönch, I. Astrand-Grundström, E. Sitnicka, Y. Sasaki, and S. E. Jacobsen. 2001. Upregulation of Flt3 expression within the bone marrow Lin (-) Sca1 (+) c-kit (+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15:659-669.
42. Osawa, M., K. Hanada, H. Hamada, and H. Nakauchi. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242-245. (Pubitemid 26285891)
43. Wang, G. G., M. P. Pasillas, and M. P. Kamps. 2005. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood 106:254-264.
44. Mackarehtschian, K., J. D. Hardin, K. A. Moore, S. Boast, S. P. Goff, and I. R. Lemischka. 1995. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147-161.
45. Mansson, R., S. Zandi, K. Anderson, I. L. Martensson, S. E. Jacobsen, D. Bryder, and M. Sigvardsson. 2008. B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells. Blood 112:1048-1055.
46. Carotta, S., A. Dakic, A. D'Amico, S. H. Pang, K. T. Greig, S. L. Nutt, and L. Wu. 2010. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32:628-641.
47. -/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene 17:2287-2293.
48. Christensen, J. L., and I. L. Weissman. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98:14541-14546.
49. Kim, K. T., K. Baird, J. Y. Ahn, P. Meltzer, M. Lilly, M. Levis, and D. Small. 2005. Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. Blood 105:1759-1767.
50. Hu, Y. L., E. Passegué, S. Fong, C. Largman, and H. J. Lawrence. 2007. Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood 109:4732-4738.
51. Domen, J., N. M. van der Lugt, D. Acton, P. W. Laird, K. Linders, and A. Berns. 1993. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J. Exp. Med. 178:1665-1673.
52. Leverson, J. D., P. J. Koskinen, F. C. Orrico, E. M. Rainio, K. J. Jalkanen, A. B. Dash, R. N. Eisenman, and S. A. Ness. 1998. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell 2:417-425.
53. Greig, K. T., C. A. de Graaf, J. M. Murphy, M. R. Carpinelli, S. H. Pang, J. Frampton, B. T. Kile, D. J. Hilton, and S. L. Nutt. 2010. Critical roles for c-Myb in lymphoid priming and early B-cell development. Blood 115:2796-2805.
54. Thorsteinsdottir, U., A. Mamo, E. Kroon, L. Jerome, J. Bijl, H. J. Lawrence, K. Humphries, and G. Sauvageau. 2002. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99:121-129.
55. Thorsteinsdottir, U., G. Sauvageau, M. R. Hough, W. Dragowska, P. M. Lansdorp, H. J. Lawrence, C. Largman, and R. K. Humphries. 1997. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol. Cell. Biol. 17:495-505.
56. Gosiengfiao, Y., R. Horvat, and A. Thompson. 2007. Transcription factors GATA-1 and Fli-1 regulate human HOXA10 expression in megakaryocytic cells. DNA Cell Biol. 26:577-587.
57. Horman, S. R., C. S. Velu, A. Chaubey, T. Bourdeau, J. Zhu, W. E. Paul, B. Gebelein, and H. L. Grimes. 2009. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood 113:5466-5475.
58. Shen, W. F., Y. L. Hu, L. Uttarwar, E. Passegue, and C. Largman. 2008. MicroRNA-126 regulates HOXA9 by binding to the homeobox. Mol. Cell. Biol. 28:4609-4619.